PVRINOX.NS(PVRINOX.NS)
PVRINOX.NS
No analyst ratings available
No analyst price targets available for PVRINOX.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $74.34B | $82.16B | $90.14B | $86.50B |
| Low | $68.71B | $75.99B | $82.95B | $79.90B |
| High | $79.01B | $90.40B | $104.79B | $95.17B |
| EBITDA Avg | $8.77B | $9.69B | $10.63B | $10.20B |
| Low | $8.11B | $8.96B | $9.79B | $9.43B |
| High | $9.32B | $10.66B | $12.36B | $11.23B |
| EBIT Avg | $140M | $154M | $169M | $163M |
| Low | $129M | $143M | $156M | $150M |
| High | $149M | $170M | $197M | $179M |
| Net Income Avg | $1.89B | $2.61B | $3.54B | $3.10B |
| Low | $1.34B | $1.81B | $2.80B | $2.80B |
| High | $2.43B | $3.41B | $4.29B | $3.51B |
| EPS Avg | $44.97 | $63.40 | $88.22 | $75.70 |
| Low | $32.63 | $44.14 | $68.20 | $68.19 |
| High | $59.33 | $83.17 | $104.60 | $85.56 |
| Analysts (Rev / EPS) | 17 / 13 | 17 / 13 | 10 / 7 | 5 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $19.02B | $20.87B | $16.49B |
| Low | $16.70B | $19.94B | $15.13B |
| High | $21.35B | $21.81B | $17.85B |
| EBITDA Avg | $2.24B | $2.46B | $1.94B |
| Low | $1.97B | $2.35B | $1.78B |
| High | $2.52B | $2.57B | $2.11B |
| EBIT Avg | $36M | $39M | $31M |
| Low | $31M | $37M | $28M |
| High | $40M | $41M | $34M |
| Net Income Avg | $471M | $1.41B | $564M |
| Low | $420M | $1.25B | $503M |
| High | $521M | $1.56B | $624M |
| EPS Avg | $4.78 | $14.25 | $5.72 |
| Low | $4.26 | $12.73 | $5.10 |
| High | $5.29 | $15.78 | $6.33 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |